Will you have Diabetes mellitus non insulin-dependent with Rapaflo - from FDA reports

Summary

There is no Diabetes mellitus non insulin-dependent reported by people who take Rapaflo yet. This review analyzes which people have Diabetes mellitus non insulin-dependent with Rapaflo. It is created by eHealthMe based on reports from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on silodosin (the active ingredients of Rapaflo) and Rapaflo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Diabetes mellitus non insulin-dependent are also considered in the study.

What is Rapaflo?

Rapaflo has active ingredients of silodosin. It is often used in prostate examination abnormal. (latest outcomes from Rapaflo 2,755 users)

What is Diabetes Mellitus Non Insulin-dependent?

Diabetes mellitus non insulin-dependent has been reported by people with schizophrenia, high blood cholesterol, breast cancer stage iv, hiv infection, nasopharyngitis (latest reports from 593 Diabetes mellitus non insulin-dependent patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 22, 2019

No report is found.


Do you have Diabetes mellitus non insulin-dependent while taking Rapaflo?

You are not alone:




Related studies

Drugs that are associated with Diabetes mellitus non insulin-dependent
Diabetes mellitus non insulin-dependent
Could your condition cause Diabetes mellitus non insulin-dependent
Diabetes mellitus non insulin-dependent
Rapaflo side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Rapaflo
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Rapaflo with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Rapaflo and have Diabetes mellitus non insulin-dependent




Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.